Literature DB >> 27327073

Prevalence of constipation among persons living in institutional geriatric-care settings - a cross-sectional study.

Kristina Lämås1, Stig Karlsson1, Anna Nolén1, Hugo Lövheim2, Per-Olof Sandman1.   

Abstract

RATIONAL: The current state of knowledge about the prevalence of constipation among persons living in institutional geriatric-care settings is limited. AIM: The aim was to investigate the prevalence of constipation among institutional geriatric-care residents and identify resident characteristics related to constipation. METHODOLOGICAL
DESIGN: In a cross-sectional study of all the institutional geriatric-care settings in a county in northern Sweden, 2970 residents were assessed. The member of staff who knew each resident best used the Multi-Dimensional Dementia Assessment Scale and the resident's records of prescribed medication to monitor cognitive function, activities in daily life, behavioural and psychological symptoms, physical restraints, speech ability, nutrition and pharmacologic agents. The study was approved by the Regional Ethical Review Board. RESULT: The prevalence of constipation was 67%. The mean age was higher among those with constipation. A significantly higher proportion of the constipated had cognitive and/or physical impairments, physical restraints, impaired speech, problems with nutrition, and higher numbers of drugs for regular use. Of those with constipation, 68% were prescribed laxatives for regular use. Twenty-three per cent of the constipated residents were prescribed opioid analgesics (n = 465), and 29% (n = 134) of these were not prescribed any laxatives. STUDY LIMITATION: Due to the cross-sectional design, the results should be interpreted with caution in terms of causal reasoning, generalisation and conclusions about risk factors. Another limitation is the use of proxy assessments of constipation.
CONCLUSION: The results show that constipation is common among residents in institutional geriatric-care settings in Sweden, which is in line with previous studies from other Western countries. Despite being constipated when having prescribed opioid analgesics, a large number did not have prescribed laxatives. The results indicate the urgency of finding strategies and implementing suitable interventions to improve bowel management in residents in institutional geriatric-care settings.
© 2016 Nordic College of Caring Science.

Entities:  

Keywords:  aged; constipation; nursing homes (residential facilities); prevalence

Mesh:

Year:  2016        PMID: 27327073     DOI: 10.1111/scs.12345

Source DB:  PubMed          Journal:  Scand J Caring Sci        ISSN: 0283-9318


  5 in total

1.  Healthcare Professionals' Experiences of Assessing, Treating and Preventing Constipation Among Older Patients During Hospitalization: An Interview Study.

Authors:  Veronica Lundberg; Anne-Marie Boström; Kristina Gottberg; Hanne Konradsen
Journal:  J Multidiscip Healthc       Date:  2020-11-16

2.  Constipation and laxative use among people living in nursing homes in 2007 and 2013.

Authors:  Maria Gustafsson; Kristina Lämås; Ulf Isaksson; Per-Olof Sandman; Hugo Lövheim
Journal:  BMC Geriatr       Date:  2019-02-08       Impact factor: 3.921

3.  Management of constipation in long-term care hospitals and its ward manager and organization factors.

Authors:  Manami Takaoka; Ayumi Igarashi; Asako Futami; Noriko Yamamoto-Mitani
Journal:  BMC Nurs       Date:  2020-01-16

4.  Prevalence of constipation and use of laxatives, and association with risk factors among older patients during hospitalization: a cross sectional study.

Authors:  Hanne Konradsen; Veronica Lundberg; Jan Florin; Anne-Marie Boström
Journal:  BMC Gastroenterol       Date:  2022-03-08       Impact factor: 3.067

5.  Safety and Efficacy of Naldemedine for the Treatment of Opioid-Induced Constipation in Patients with Chronic Non-Cancer Pain Receiving Opioid Therapy: A Subgroup Analysis of Patients ≥ 65 Years of Age.

Authors:  James Wild; Lynn Webster; Tadaaki Yamada; Martin Hale
Journal:  Drugs Aging       Date:  2020-04       Impact factor: 4.271

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.